MakeMoneyCoESTB2020

MakeMoneyCoESTB2020

Reasons for likely short pull back : FCX is encountering a historical/psychological resistance @ ~$40. FCX is at the top of its current Pitchfork price channel. FCX is overbought (above 75 on RSI). Reasons for likely recovery : Fundamental Analysis - there is a shortage of copper for surge in post COVID extreme lockdown manufacturing. ...

MakeMoneyCoESTB2020

Fundamental analysis indicates HRB will continue to perform well under COVID restrictions, especially as newly implemented vaccinations bolster its broader market within the tax industry that includes face to face consultations (unlike intuit - TurboTax). The US is also entering its historic tax preparation season, following the holidays. Sentimental...

MakeMoneyCoESTB2020

Fundamental analysis indicates IVR has seen the worst of its COVID related impacts, since 23MAR20 it has slowly been recovering (roughly 80%). Sentimental analysis sets the stage for a continued recovery as the housing market performs well as interest rates are being kept low encouraging purchases. Technical analysis shows IVR has developed a pattern of...

MakeMoneyCoESTB2020

Fundamental analysis indicates DKS will continue to perform well under COVID restrictions. In light of vaccine news, DKS has poised itself well with new stores and additional workers to capitalize on increased brick & mortar foot traffic. Sentimental analysis sets the stage for a strong rebound (earnings , new product line , positive post-COVID performance ...

MakeMoneyCoESTB2020

WBA hit and reversed from $43.35 historical resistance. The 13 SMA & 30 SMA are preparing to cross, the MACD pre-confirmation has already occurred, historically indicating reversals for this stock. There is looming vaccine news that can impact performance but if news is mired in political discourse, reversal should hold. Got in at $1.34, looking to sell at $2.68...

MakeMoneyCoESTB2020

JNJ broke through 200 SMA. The 13 SMA & 30 SMA are preparing to cross, the MACD pre-confirmation has already occurred, historically indicating reversals for this stock. There is looming vaccine news that can impact performance but if news is mired in political discourse, reversal should hold. Got in at $1.48, looking to sell at $2.95 o/a 18NOV. $0.90 stop loss...